Thursday, October 20th, 2016 in Medical Industry News, Medical Research.
Crohn’s disease belongs to a group of conditions known as Inflammatory Bowel Diseases (IBD). Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract. Crohn’s disease can affect any part of the GI tract. While symptoms vary from patient to patient, the common symptoms of Crohn’s disease include persistent diarrhea, rectal bleeding, urgent need Read more…
Thursday, October 13th, 2016 in Cancer Research, Medical Industry News, Medical Research.
More than 1 million people in the United States live daily with Parkinson’s disease. The disease systematically takes away the patient’s motor abilities, leaving them with a slow and labored gait, rigid limbs, tremors, shuffling and a lack of balance. A recent study , reported in the journal Science in the last week, suggests that Read more…
Monday, October 3rd, 2016 in Cancer Research.
Nanoparticles are tiny particles with at least one dimension no bigger than 100 nanometers. When compared with the same material on a larger scale, they exhibit unique characteristics which are now being researched for use in biomedicine and electronics. The nanoparticles at the center of a new study – called Cornell dots, or C dots Read more…
Friday, September 30th, 2016 in General, Specialty Surgery.
Although undesirable, morning sickness is very common, and may actually indicate a healthy pregnancy. Although the illness most commonly occurs in the morning hours and peaks in the third month of pregnancy, many expectant mothers suffer through the unpleasant reality regardless of the time of day, and through their entire pregnancy. Fact: It is estimated Read more…
Monday, September 26th, 2016 in Healthcare Technology Development, Medical Research.
Denali Therapeutics, the company formed last year by three former executives of legendary Genentech to develop Alzheimer’s, Parkinson’s and ALS treatment, is beginning to share their plans for the $217 million raised in venture capital. Announcing that they have raised another $130 million from investors, Marc Tessier-Lavigne, a well-known neuroscientist, president of Rockefeller University in New Read more…
Thursday, September 15th, 2016 in Medical Field: Urgent Care, Medical Industry News, Specialty Primary Care.
Sepsis is the presence of harmful bacteria and their toxins in tissues, typically originating from infection of a wound. Half of all hospital deaths are caused by sepsis; Dr. Martin Doerfler, senior vice president of clinical strategy and development at the North Shore-LIJ Health System, says the blood infection is a problem because it doesn’t Read more…
Wednesday, September 7th, 2016 in Medical Field: Trauma/Emergency, Medical Field: Urgent Care, Medical Research, Specialty Primary Care.
According to the CDC, traumatic brain injuries account for more than 2 million emergency room visits annually in the U.S. The majority of these injuries are considered non-life threatening, including concussions; although awareness regarding the possibility of complications resulting from a concussion has risen in recent years. Studies have determined that chronic traumatic encephalopathy (CTE), Read more…
Thursday, September 1st, 2016 in General.
Health care needs are on the rise in our country. Although the population as a whole is getting older, demand is up in every age demographic. We need more physicians. Costs are rising. The two most visited disciplines – primary care and general practice– are trying to integrate new technology and efficiencies into an archaic Read more…
Tuesday, August 23rd, 2016 in Medical Field: Hospitalist, Medical Industry News.
For the last 5 decades, more than 33 million people check into hospitals per year – that is basically a person every second. Sadly, even with the sheer number of patients coming through for commonplace treatments, too many hospitals still struggle to reach standards of excellence. To help consumers choose the best local hospital for Read more…
Friday, August 19th, 2016 in Medical Research.
As recently reported on WSJ.com, it is estimated that 1.7 million patients participate in 80,000 drug-company sponsored trials globally each year. Researchers are finding it more difficult to attract and retain the requested number of patients in order to complete studies on time and within budget. There are significant challenges to clinical drug trial Read more…
